Sherrill Joseph H Jr - Net Worth and Insider Trading

Sherrill Joseph H Jr Net Worth

The estimated net worth of Sherrill Joseph H Jr is at least $4 Million dollars as of 2024-09-21. Sherrill Joseph H Jr is the Director of BioCryst Pharmaceuticals Inc and owns about 492,000 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $4 Million. Details can be seen in Sherrill Joseph H Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sherrill Joseph H Jr has not made any transactions after 2003-08-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sherrill Joseph H Jr

To

Sherrill Joseph H Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sherrill Joseph H Jr owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .

Click here to see the complete history of Sherrill Joseph H Jr’s form 4 insider trades.

Insider Ownership Summary of Sherrill Joseph H Jr

Ticker Comapny Transaction Date Type of Owner
BCRX BioCryst Pharmaceuticals Inc 2003-08-07 director

Sherrill Joseph H Jr Latest Holdings Summary

Sherrill Joseph H Jr currently owns a total of 1 stock. Sherrill Joseph H Jr owns 492,000 shares of BioCryst Pharmaceuticals Inc (BCRX) as of August 7, 2003, with a value of $4 Million.

Latest Holdings of Sherrill Joseph H Jr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCRX BioCryst Pharmaceuticals Inc 2003-08-07 492,000 8.11 3,990,120

Holding Weightings of Sherrill Joseph H Jr


Sherrill Joseph H Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Sherrill Joseph H Jr has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 7,700 shares on August 7, 2003, which cost Sherrill Joseph H Jr around $36,575.

Insider Trading History of Sherrill Joseph H Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sherrill Joseph H Jr Trading Performance

GuruFocus tracks the stock performance after each of Sherrill Joseph H Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sherrill Joseph H Jr is 93.66%. GuruFocus also compares Sherrill Joseph H Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sherrill Joseph H Jr within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sherrill Joseph H Jr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sherrill Joseph H Jr

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.59 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 20.49 LIMIT LIMIT LIMIT LIMIT LIMIT

Sherrill Joseph H Jr Ownership Network

Ownership Network List of Sherrill Joseph H Jr

No Data

Ownership Network Relation of Sherrill Joseph H Jr

Insider Network Chart

Sherrill Joseph H Jr Owned Company Details

What does BioCryst Pharmaceuticals Inc do?

Who are the key executives at BioCryst Pharmaceuticals Inc?

Sherrill Joseph H Jr is the director of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .

BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary

Over the past 18 months, Sherrill Joseph H Jr made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net purchase of 23,000 shares made by Helen M. Thackray , a net sale of 8,689 shares made by Machelle Sanders , and a net sale of 7,866 shares made by Nancy J Hutson .

In summary, during the past 3 months, insiders sold 8,600 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 8,600 shares. During the past 18 months, 43,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 139,748 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioCryst Pharmaceuticals Inc Insider Transactions

No Available Data

Sherrill Joseph H Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Sherrill Joseph H Jr. You might contact Sherrill Joseph H Jr via mailing address: 1510 Stickney Point Rd, Sarasota Fl 34231.

Discussions on Sherrill Joseph H Jr

No discussions yet.